LYPD4 and breast cancer: Figure 4 displays the relative levels of exosome release, with data representing the mean ± SD of three independent experiments. This visual representation clearly shows the differences in exosome secretion between the various treatments. Thus, Figure 4 highlights the potential impact of SMR, Mortalin, and Vimentin peptides on exosome secretion in BC cells, which could be crucial for developing new treatments targeting exosome-mediated pathways in cancer progression.